Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Bjørndal

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Lancet (London, England)|December 24, 1977
Bumetanide-induced hyperamylaseaemia in patients with renal insufficiencyF Lynggaard, N Bjørndal
Ugeskrift for Laeger|July 30, 1979
[Koffinautin abuse: an increasing problem]N Bjørndal, P Nørgaard
Ugeskrift for Laeger|May 8, 1978
[Bumetanide (Burinex) in high oral doses in patients with chronic renal insufficiency. A preliminary report]N Bjørndal, F Lynggaard
Psychopharmacology|January 1, 1984
Methylphenidate, apomorphine, THIP, and diazepam in monkeys: dopamine-GABA behavior related to psychoses and tardive dyskinesiaJ Gerlach, N Bjørndal, E Christensson
Sykepleien. Fag|December 7, 1992
[Homeopathy and research]A N Bjørndal, P A Straumsheim
Advances in Biochemical Psychopharmacology|January 1, 1980
Dopamine antagonist and agonist treatment of tardive dyskinesiaN Bjørndal, D Casey, J Gerlach
Ugeskrift for Laeger|February 21, 1983
[Malignant neuroleptic syndrome]N Bjørndal, J Remvig, P Gottlieb
Psychopharmacology|January 1, 1980
Enkephalin, morphine, and naloxone in tardive dyskinesiaN Bjørndal, D E Casey, J Gerlach
Psychopharmacology|January 1, 1982
Levodopa and receptor sensitivity modification in tardive dyskinesiaD E Casey, J Gerlach, N Bjørndal
Ugeskrift for Laeger|July 31, 1989
[Somatic disease at a department for acute psychiatric disease]K Solstad, B Glenthøj, N Bjørndal, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Lancet (London, England)|December 24, 1977
Bumetanide-induced hyperamylaseaemia in patients with renal insufficiencyF Lynggaard, N Bjørndal
Ugeskrift for Laeger|July 30, 1979
[Koffinautin abuse: an increasing problem]N Bjørndal, P Nørgaard
Ugeskrift for Laeger|May 8, 1978
[Bumetanide (Burinex) in high oral doses in patients with chronic renal insufficiency. A preliminary report]N Bjørndal, F Lynggaard
Psychopharmacology|January 1, 1984
Methylphenidate, apomorphine, THIP, and diazepam in monkeys: dopamine-GABA behavior related to psychoses and tardive dyskinesiaJ Gerlach, N Bjørndal, E Christensson
Sykepleien. Fag|December 7, 1992
[Homeopathy and research]A N Bjørndal, P A Straumsheim
Advances in Biochemical Psychopharmacology|January 1, 1980
Dopamine antagonist and agonist treatment of tardive dyskinesiaN Bjørndal, D Casey, J Gerlach
Ugeskrift for Laeger|February 21, 1983
[Malignant neuroleptic syndrome]N Bjørndal, J Remvig, P Gottlieb
Psychopharmacology|January 1, 1980
Enkephalin, morphine, and naloxone in tardive dyskinesiaN Bjørndal, D E Casey, J Gerlach
Psychopharmacology|January 1, 1982
Levodopa and receptor sensitivity modification in tardive dyskinesiaD E Casey, J Gerlach, N Bjørndal
Ugeskrift for Laeger|July 31, 1989
[Somatic disease at a department for acute psychiatric disease]K Solstad, B Glenthøj, N Bjørndal, et al.
Pageof 2